0.1898CHF-12.53%Mkt Cap: —P/E: —1d ago
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod syste…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)732.72K $
Gross Profit674.51K $
Net Income (TTM)-11.31M $
Revenue/Share0.0354 USD
Last Price0.1898 CHF
Fiscal Year EndDec 2025
MR Quarter—
Employees10
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.76
EPS (TTM)-0.01
EPS (Forward)—
52W Range
0.18980% of range0.2300
52W High0.2300 CHF
52W Low0.1898 CHF
Profitability
Gross Margin92.06%
Oper. Margin-1637.85%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-51.56%
ROA-25.46%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.23M $
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio1.20
Quick Ratio1.05
Book Value/Sh0.2510 CHF
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split0.0025:1
Split DateMay 5, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.633.95M
Float37.20M
Insiders48.55%
Institutions18.52%
Technical
SMA 501.677 (-88.7%)
SMA 2002.579 (-92.6%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)123.07K
Avg Vol (10d)77
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—